Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
BACKGROUND: In the era of computer-assisted diagnostic tools for various brain diseases, Alzheimer's disease (AD) covers a large percentage of neuroimaging research, with the main scope being its use in daily practice. However, there has been no study attempting to simultaneously discriminate among Healthy Controls (HC), early mild cognitive impairment (MCI), late MCI (cMCI) and stable AD, using f...
BACKGROUND: Alzheimer's disease (AD) is the most common cause of dementia in the elderly and affects approximately 30 million individuals worldwide. Mild cognitive impairment (MCI) is very frequently a prodromal phase of AD, and existing studies have suggested that people with MCI tend to progress to AD at a rate of about 10-15% per year. However, the ability of clinicians and machine learning sys...
INTRODUCTION: Currently, 47 million people have dementia, worldwide, often requiring paid care by formal caregivers. Research regarding family caregiv...
This research aims to improve patient transfers by developing a new type of advanced robotic assist device. It has multiple actuated degrees of freedo...
Computerized healthcare has undergone rapid development thanks to the advances in medical imaging and machine learning technologies. Especially, recen...
BACKGROUND: We present our results in the International challenge for automated prediction of MCI from MRI data. We evaluate the performance of MRI-ba...
BACKGROUND: Alzheimer's disease (AD) is the most common cause of neurodegenerative dementia in the elderly population. Scientific research is very act...
OBJECTIVE: To discover lead lupane triterpenoid's potential isolated from Pueraria lobata roots against β-site amyloid precursor protein cleaving enzy...
Alzheimer's disease (AD) has been not only a substantial financial burden to the health care system but also an emotional burden to patients and their...
Alzheimer's disease (AD) is a highly prevalent condition and its prevalence is expected to further increase due to the aging of the general population...
OBJECTIVE: To conduct the first support vector machine (SVM)-based study comparing the diagnostic accuracy of T1-weighted magnetic resonance imaging (...
OBJECTIVES: This scoping study is the first step of a multiphase, international project aimed at designing a homecare robot that can provide functiona...
The use of Intelligent Assistive Technology (IAT) in dementia care opens the prospects of reducing the global burden of dementia and enabling novel op...
OBJECTIVE: Diabetic neuropathy is a chronic and often disabling condition that affects a significant number of individuals with diabetes mellitus (DM)...
BACKGROUND AND OBJECTIVES: A huge number of solutions based on computational systems have been recently developed for the classification of cognitive ...
BACKGROUND: Socially assistive robots are increasingly used as a therapeutic tool for people with dementia, as a means to improve quality of life thro...
BACKGROUND AND OBJECTIVE: Alzheimers disease (AD) is a fatal neurodegenerative disease and the onset of AD is insidious. Full understanding of the AD-...
OBJECTIVES: To test the effects of individual, nonfacilitated sessions with PARO (version 9), when compared against a look-alike plush toy and usual c...
Utilizing [18F]-AV-1451 tau positron emission tomography (PET) as an Alzheimer disease (AD) biomarker will require identification of brain regions tha...
BACKGROUND: Predicting progression from a stage of Mild Cognitive Impairment to dementia is a major pursuit in current research. It is broadly accepte...